Lennar Corporation (LEN-B) Stock Competitors & Peer Comparison
See (LEN-B) competitors and their performances in Stock Market.
Peer Comparison Table: Residential Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LEN-B | $85.02 | -1.05% | 21.6B | 13.26 | $6.42 | +2.31% |
| DHI | $155.72 | -0.74% | 44.1B | 14.57 | $10.67 | +1.12% |
| PHM | $129.92 | -1.11% | 24.7B | 12.54 | $10.36 | +0.77% |
| LEN | $86.74 | -1.04% | 21.5B | 14.22 | $6.10 | +2.31% |
| NVR | $6,693.69 | +0.00% | 18.1B | 30.05 | $222.76 | N/A |
| TOL | $151.64 | -2.25% | 14.2B | 11.47 | $13.22 | +0.66% |
| TMHC | $71.77 | -0.11% | 6.6B | 10.02 | $7.16 | N/A |
| IBP | $222.19 | -1.57% | 6B | 19.91 | $11.16 | +1.50% |
| MTH | $78.31 | -1.99% | 5.2B | 13.13 | $5.96 | +2.31% |
| MDC | $62.98 | +0.05% | 4.7B | 11.91 | $5.29 | +3.41% |
Stock Comparison
LEN-B vs DHI Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, DHI has a market cap of 44.1B. Regarding current trading prices, LEN-B is priced at $85.02, while DHI trades at $155.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas DHI's P/E ratio is 14.57. In terms of profitability, LEN-B's ROE is +0.07%, compared to DHI's ROE of +0.13%. Regarding short-term risk, LEN-B is more volatile compared to DHI. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check DHI's competition here
LEN-B vs PHM Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, PHM has a market cap of 24.7B. Regarding current trading prices, LEN-B is priced at $85.02, while PHM trades at $129.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas PHM's P/E ratio is 12.54. In terms of profitability, LEN-B's ROE is +0.07%, compared to PHM's ROE of +0.16%. Regarding short-term risk, LEN-B is more volatile compared to PHM. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check PHM's competition here
LEN-B vs LEN Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, LEN has a market cap of 21.5B. Regarding current trading prices, LEN-B is priced at $85.02, while LEN trades at $86.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas LEN's P/E ratio is 14.22. In terms of profitability, LEN-B's ROE is +0.07%, compared to LEN's ROE of +0.07%. Regarding short-term risk, LEN-B is more volatile compared to LEN. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check LEN's competition here
LEN-B vs NVR Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, NVR has a market cap of 18.1B. Regarding current trading prices, LEN-B is priced at $85.02, while NVR trades at $6,693.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas NVR's P/E ratio is 30.05. In terms of profitability, LEN-B's ROE is +0.07%, compared to NVR's ROE of +0.33%. Regarding short-term risk, LEN-B is more volatile compared to NVR. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check NVR's competition here
LEN-B vs TOL Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, TOL has a market cap of 14.2B. Regarding current trading prices, LEN-B is priced at $85.02, while TOL trades at $151.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas TOL's P/E ratio is 11.47. In terms of profitability, LEN-B's ROE is +0.07%, compared to TOL's ROE of +0.15%. Regarding short-term risk, LEN-B is less volatile compared to TOL. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check TOL's competition here
LEN-B vs TMHC Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, TMHC has a market cap of 6.6B. Regarding current trading prices, LEN-B is priced at $85.02, while TMHC trades at $71.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas TMHC's P/E ratio is 10.02. In terms of profitability, LEN-B's ROE is +0.07%, compared to TMHC's ROE of +0.11%. Regarding short-term risk, LEN-B is more volatile compared to TMHC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check TMHC's competition here
LEN-B vs IBP Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, IBP has a market cap of 6B. Regarding current trading prices, LEN-B is priced at $85.02, while IBP trades at $222.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas IBP's P/E ratio is 19.91. In terms of profitability, LEN-B's ROE is +0.07%, compared to IBP's ROE of +0.37%. Regarding short-term risk, LEN-B is less volatile compared to IBP. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check IBP's competition here
LEN-B vs MTH Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, MTH has a market cap of 5.2B. Regarding current trading prices, LEN-B is priced at $85.02, while MTH trades at $78.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas MTH's P/E ratio is 13.13. In terms of profitability, LEN-B's ROE is +0.07%, compared to MTH's ROE of +0.07%. Regarding short-term risk, LEN-B is more volatile compared to MTH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check MTH's competition here
LEN-B vs MDC Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, MDC has a market cap of 4.7B. Regarding current trading prices, LEN-B is priced at $85.02, while MDC trades at $62.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas MDC's P/E ratio is 11.91. In terms of profitability, LEN-B's ROE is +0.07%, compared to MDC's ROE of +0.02%. Regarding short-term risk, LEN-B is more volatile compared to MDC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check MDC's competition here
LEN-B vs SKY Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, SKY has a market cap of 4.6B. Regarding current trading prices, LEN-B is priced at $85.02, while SKY trades at $82.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas SKY's P/E ratio is 21.53. In terms of profitability, LEN-B's ROE is +0.07%, compared to SKY's ROE of +0.13%. Regarding short-term risk, LEN-B is less volatile compared to SKY. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check SKY's competition here
LEN-B vs CVCO Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, CVCO has a market cap of 4.5B. Regarding current trading prices, LEN-B is priced at $85.02, while CVCO trades at $578.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas CVCO's P/E ratio is 24.15. In terms of profitability, LEN-B's ROE is +0.07%, compared to CVCO's ROE of +0.18%. Regarding short-term risk, LEN-B is less volatile compared to CVCO. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check CVCO's competition here
LEN-B vs TPH Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, TPH has a market cap of 4B. Regarding current trading prices, LEN-B is priced at $85.02, while TPH trades at $46.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas TPH's P/E ratio is 22.36. In terms of profitability, LEN-B's ROE is +0.07%, compared to TPH's ROE of +0.06%. Regarding short-term risk, LEN-B is more volatile compared to TPH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check TPH's competition here
LEN-B vs MHO Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, MHO has a market cap of 3.9B. Regarding current trading prices, LEN-B is priced at $85.02, while MHO trades at $150.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas MHO's P/E ratio is 10.00. In terms of profitability, LEN-B's ROE is +0.07%, compared to MHO's ROE of +0.11%. Regarding short-term risk, LEN-B is more volatile compared to MHO. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check MHO's competition here
LEN-B vs KBH Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, KBH has a market cap of 3.7B. Regarding current trading prices, LEN-B is priced at $85.02, while KBH trades at $58.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas KBH's P/E ratio is 11.55. In terms of profitability, LEN-B's ROE is +0.07%, compared to KBH's ROE of +0.07%. Regarding short-term risk, LEN-B is less volatile compared to KBH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check KBH's competition here
LEN-B vs GRBK-PA Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, GRBK-PA has a market cap of 3.5B. Regarding current trading prices, LEN-B is priced at $85.02, while GRBK-PA trades at $23.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas GRBK-PA's P/E ratio is 3.44. In terms of profitability, LEN-B's ROE is +0.07%, compared to GRBK-PA's ROE of +0.16%. Regarding short-term risk, LEN-B is less volatile compared to GRBK-PA. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check GRBK-PA's competition here
LEN-B vs GRBK Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, GRBK has a market cap of 3.2B. Regarding current trading prices, LEN-B is priced at $85.02, while GRBK trades at $74.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas GRBK's P/E ratio is 11.01. In terms of profitability, LEN-B's ROE is +0.07%, compared to GRBK's ROE of +0.16%. Regarding short-term risk, LEN-B is less volatile compared to GRBK. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check GRBK's competition here
LEN-B vs HOVNP Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, HOVNP has a market cap of 3B. Regarding current trading prices, LEN-B is priced at $85.02, while HOVNP trades at $20.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas HOVNP's P/E ratio is 2.72. In terms of profitability, LEN-B's ROE is +0.07%, compared to HOVNP's ROE of +0.04%. Regarding short-term risk, LEN-B is more volatile compared to HOVNP. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check HOVNP's competition here
LEN-B vs CCS Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, CCS has a market cap of 1.9B. Regarding current trading prices, LEN-B is priced at $85.02, while CCS trades at $65.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas CCS's P/E ratio is 12.22. In terms of profitability, LEN-B's ROE is +0.07%, compared to CCS's ROE of +0.05%. Regarding short-term risk, LEN-B is more volatile compared to CCS. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check CCS's competition here
LEN-B vs DFH Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, DFH has a market cap of 1.5B. Regarding current trading prices, LEN-B is priced at $85.02, while DFH trades at $16.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas DFH's P/E ratio is 9.66. In terms of profitability, LEN-B's ROE is +0.07%, compared to DFH's ROE of +0.11%. Regarding short-term risk, LEN-B is more volatile compared to DFH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check DFH's competition here
LEN-B vs LGIH Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, LGIH has a market cap of 1.4B. Regarding current trading prices, LEN-B is priced at $85.02, while LGIH trades at $58.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas LGIH's P/E ratio is 17.23. In terms of profitability, LEN-B's ROE is +0.07%, compared to LGIH's ROE of +0.03%. Regarding short-term risk, LEN-B is less volatile compared to LGIH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check LGIH's competition here
LEN-B vs BZH Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, BZH has a market cap of 747.9M. Regarding current trading prices, LEN-B is priced at $85.02, while BZH trades at $27.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas BZH's P/E ratio is 68.40. In terms of profitability, LEN-B's ROE is +0.07%, compared to BZH's ROE of -0.00%. Regarding short-term risk, LEN-B is less volatile compared to BZH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check BZH's competition here
LEN-B vs HOV Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, HOV has a market cap of 644.5M. Regarding current trading prices, LEN-B is priced at $85.02, while HOV trades at $127.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas HOV's P/E ratio is 12.57. In terms of profitability, LEN-B's ROE is +0.07%, compared to HOV's ROE of +0.04%. Regarding short-term risk, LEN-B is more volatile compared to HOV. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check HOV's competition here
LEN-B vs LEGH Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, LEGH has a market cap of 616.7M. Regarding current trading prices, LEN-B is priced at $85.02, while LEGH trades at $25.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas LEGH's P/E ratio is 14.57. In terms of profitability, LEN-B's ROE is +0.07%, compared to LEGH's ROE of +0.08%. Regarding short-term risk, LEN-B is more volatile compared to LEGH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check LEGH's competition here
LEN-B vs SIC Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, SIC has a market cap of 376M. Regarding current trading prices, LEN-B is priced at $85.02, while SIC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas SIC's P/E ratio is 7.11. In terms of profitability, LEN-B's ROE is +0.07%, compared to SIC's ROE of -0.06%. Regarding short-term risk, LEN-B is more volatile compared to SIC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check SIC's competition here
LEN-B vs UHG Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, UHG has a market cap of 71.8M. Regarding current trading prices, LEN-B is priced at $85.02, while UHG trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas UHG's P/E ratio is -4.36. In terms of profitability, LEN-B's ROE is +0.07%, compared to UHG's ROE of -0.23%. Regarding short-term risk, LEN-B is less volatile compared to UHG. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check UHG's competition here
LEN-B vs SPHL Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, SPHL has a market cap of 5.5M. Regarding current trading prices, LEN-B is priced at $85.02, while SPHL trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas SPHL's P/E ratio is -20.69. In terms of profitability, LEN-B's ROE is +0.07%, compared to SPHL's ROE of -0.37%. Regarding short-term risk, LEN-B is less volatile compared to SPHL. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check SPHL's competition here
LEN-B vs NWHM Comparison July 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 21.6B. In comparison, NWHM has a market cap of 0. Regarding current trading prices, LEN-B is priced at $85.02, while NWHM trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.26, whereas NWHM's P/E ratio is N/A. In terms of profitability, LEN-B's ROE is +0.07%, compared to NWHM's ROE of -0.15%. Regarding short-term risk, LEN-B is more volatile compared to NWHM. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check NWHM's competition here